Triamcinolone

This classification denotes a therapeutic glucocorticoid with the molecular formula C21H27FO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1ZK20VI6TY, chemically known as pregna-1,4-diene-3,20-dione, 9-fluoro-11,16,17,21-tetrahydroxy-, (11.beta.,16.alpha.)- but generally known as triamcinolone, which bears US NIH Compound Identifier 5544. European Medicines Agency schedules Triamcinolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11251MIG. The term TRIAMCINOLONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules triamcinolone in its Anatomical Therapeutic Chemical (ATC) Classification. TRIAMCINOLONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule triamcinolone under HS 29372200 and SITC 54153. As of Q4 2014, TRIAMCINOLONE remains the US FDA Preferred Term for this commodity. Triamcinolone bears US NLM identifiers UMLS ID C0040864 and NCI Concept Code C901. SMILES: FC12C(C3C(C(O)(C(O)C3)C(=O)CO)(CC1O)C)CCC1=CC(=O)C=CC21C.